Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Sponsor: Yonsei University
Summary
The aim of this study is to investigate the effect of Gliatamin (chonline alphoscerate) on depressive mood in type 2 diabetes patients and demonstrate the impact of improved depressive mood could be influence the patient's quality of life and glycemic control.
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2016-06-01
Completion Date
2025-06-30
Last Updated
2025-02-24
Healthy Volunteers
No
Conditions
Interventions
Chonline Alphoscerate
Patients treated with Chonline Alphoscerate as add on therapy to their medication
Placebo Oral Tablet
Patients maintain their medication with either Gliatamin or placebo for 6 months.
Locations (1)
Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center
Seoul, South Korea